Répertoire du corps professoral

Financements des 2 dernières années

Manufacturing of antigens and adjuvants for development of vaccines (MAAV)
Programme: Fonds d'innovation (FI)
Organisme(s) subventionnaire(s): Fondation Canadienne pour l'innovation (La), Ministère de la Santé et des Services sociaux, Fondation du CHU de Québec
Type de financement: Subvention
Établissement tête: Université Laval
Du 1 juillet 2021 au31 mars 2024

Publications des 5 dernières années

Modulation of Antigen Display on PapMV Nanoparticles Influences Its Immunogenicity. Vaccines, 2021/01. Laliberté-Gagné ME, Bolduc M, Garneau C, Olivera-Ugarte SM, Savard P, Leclerc D. DOI 10.3390/vaccines9010033

Modulation of Antigen Display on PapMV Nanoparticles Influences Its Immunogenicity 2020/12. Laliberté-Gagné M, Bolduc M, Garneau C, Olivera-Ugarte S, Savard P, Leclerc D. DOI 10.20944/preprints202012.0327.v1

A Randomized Controlled Study to Evaluate the Safety and Reactogenicity of a Novel rVLP-Based Plant Virus Nanoparticle Adjuvant Combined with Seasonal Trivalent Influenza Vaccine Following Single Immunization in Healthy Adults 18-50 Years of Age. Vaccines, 2020/07. Langley J, Pastural E, Halperin S, McNeil S, ElSherif M, MacKinnon-Cameron D, Ye L, Grange C, Thibodeau V, Cailhier JF, Lapointe R, McElhaney J, Savard P. DOI 10.3390/vaccines8030393

2744. A Phase I Randomized, Observer-Blind, Controlled, Dose Escalation Trial of the Safety and Tolerability of a Single Intramuscular Dose of a PAL Adjuvant (Laboratory Code, FB-631) Co-administered with Seasonal TIV (2013–2014) to Healthy Adults ≥18–50 Years of Age Open forum infectious diseases, 2019/10. Langley J, Pastural E, Halperin S, Halperin S, McNeil S, ElSherif M, MacKinnon-Cameron D, Ye L, Lapointe R, McElhaney J, Martin L, Bolduc M, Savard P.

Increased Immunogenicity of Full-Length Protein Antigens through Sortase-Mediated Coupling on the PapMV Vaccine Platform. Vaccines, 2019/06. Laliberté-Gagné MÈ, Bolduc M, Thérien A, Garneau C, Casault P, Savard P, Estaquier J, Leclerc D. DOI 10.3390/vaccines7020049